U.S. Software Stock News

NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Advances ABCL635 Menopause Candidate As Shares Trade Below Targets

AbCellera Biologics (NasdaqGS:ABCL) has begun dosing patients in the Phase 2 portion of its Phase 1/2 clinical trial for ABCL635. ABCL635 is a non hormonal candidate for treating moderate to severe vasomotor symptoms associated with menopause. This Phase 2 dosing milestone marks further clinical progress in the company's efforts to develop a potential first in class menopause therapy. AbCellera Biologics, known for its antibody discovery platform, is pushing deeper into clinical development...
NYSE:VFC
NYSE:VFCLuxury

VF Corp (VFC) Q3 Profit Rebound Tests Valuation Concerns In Bullish Narratives

V.F. Corporation (VFC) just posted Q3 2026 results with revenue of US$2.9b and basic EPS of US$0.77, setting a clear reference point for how the year is shaping up. The company has seen quarterly revenue move from US$2.8b in Q2 2026 and US$2.9b in Q3 2025, while EPS shifted from US$0.49 in Q2 2026 and US$0.43 in Q3 2025, giving investors a clean view of how the income statement is trending as margins settle after a volatile period. See our full analysis for V.F. With the latest numbers on the...
NYSE:EIG
NYSE:EIGInsurance

Assessing Employers Holdings (EIG) Valuation After Insider Buying And A Key Technical Breakout

A senior executive at Employers Holdings (EIG) recently bought shares, and the stock has moved above a widely watched long term moving average. These developments are attracting fresh attention from investors tracking sentiment and trend signals. See our latest analysis for Employers Holdings. That insider purchase and move above a long term average comes after a 90 day share price return of 17.23% and a 5 year total shareholder return of 71.83%, suggesting momentum has picked up recently...
NYSE:FFWM
NYSE:FFWMBanks

First Foundation (FFWM) Q4 Loss Persists And Keeps Bearish Profitability Narratives In Focus

First Foundation (FFWM) just posted its FY 2025 fourth quarter numbers with total revenue of US$54.9 million and a basic EPS loss of US$0.10, as the bank continues to work through a period of unprofitable results. Over the past year, the company has seen trailing twelve month revenue of US$170.5 million against a basic EPS loss of US$1.88, which sets a clear backdrop of earnings pressure even as top line activity remains meaningful. With margins still under strain, the latest release puts the...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Platforms (META) Margin Compression Challenges Bullish Growth Narratives In FY 2025 Results

Meta Platforms FY 2025 earnings snapshot Meta Platforms (META) has wrapped up FY 2025 with fourth quarter revenue of about US$59.9b and basic EPS of US$9.02, alongside net income of roughly US$22.8b. The latest twelve month figures show total revenue of about US$201.0b with basic EPS of US$23.98 and net income of around US$60.5b. The company has seen quarterly revenue move from roughly US$48.4b and EPS of US$8.24 in Q4 2024 to about US$59.9b and EPS of US$9.02 in Q4 2025, with trailing net...
NasdaqCM:CODA
NasdaqCM:CODAElectronic

Coda Octopus Group (CODA) Margin Slippage Tests Bullish Earnings Growth Narratives

Coda Octopus Group (CODA) closed out FY 2025 with Q4 revenue of US$7.3 million and basic EPS of US$0.09, alongside net income of US$1.0 million that builds on a trailing 12 month net income base of US$4.1 million. The company has seen quarterly revenue move from US$5.1 million in Q1 2025 to US$7.3 million in Q4, while basic EPS ranged between US$0.08 and US$0.11 over the year. This sets up a picture where investors are weighing higher recent profit levels against net margins that have...
OTCPK:CHBH
OTCPK:CHBHBanks

Croghan Bancshares (OTCPK:CHBH) 24.4% Net Margin Challenges Long Running Earnings Decline Narrative

Croghan Bancshares (CHBH) just wrapped up FY 2025 with Q4 total revenue of US$12.6 million and basic EPS of US$1.64, supported by quarterly net income of US$3.3 million. The company has seen quarterly revenue move from US$11.0 million in Q4 2024 to US$12.6 million in Q4 2025, while basic EPS over the same quarters shifted from US$1.11 to US$1.64, resulting in a year where trailing twelve month net profit margin was 24.4%. For investors, that combination of higher recent earnings quality and...
NYSE:FICO
NYSE:FICOSoftware

FICO Q1 2026 Margins Near 32% Reinforce Bullish Quality Earnings Narrative

Q1 2026 headline numbers set the tone Fair Isaac (FICO) opened its fiscal 2026 story with Q1 revenue of US$512 million and basic EPS of US$6.68, alongside net income excluding extra items of US$158 million, putting fresh numbers in front of investors watching how the franchise is progressing. The company has seen quarterly revenue move from US$440 million in Q1 2025 to US$512 million in Q1 2026, while basic EPS shifted from US$6.26 to US$6.68 over the same span. This provides a clear read on...
NYSE:CSW
NYSE:CSWBuilding

CSW Industrials (CSWI) Margin Improvement Tests Bullish Earnings Narratives

CSW Industrials (CSWI) has put up another solid quarter in Q3 2026, with quarterly context showing revenue moving from US$193.6 million in Q3 2025 to US$276.9 million in Q2 2026. EPS shifted from US$1.60 to US$2.42 over the same period, and trailing twelve month EPS reached US$8.55 on revenue of US$964.8 million. Over the last year, net income for the trailing twelve months rose from US$115.6 million to US$143.6 million as margins widened from 13.8% to 14.9%. This sets the scene for investors...
NasdaqCM:CRDF
NasdaqCM:CRDFBiotechs

Cardiff Oncology (CRDF) Valuation Check After New Onvansertib Phase 2 Data And Leadership Changes

Why Cardiff Oncology is back on investors’ radar Cardiff Oncology (CRDF) has drawn fresh attention after reporting dose dependent Phase 2 data for onvansertib in first line RAS mutated metastatic colorectal cancer, while also announcing a leadership shake up, including a new interim CEO. See our latest analysis for Cardiff Oncology. The encouraging onvansertib data and leadership changes have arrived during a weak share price stretch, with a 7 day share price return of 45.6% decline and a 1...
NasdaqGM:ASTL
NasdaqGM:ASTLMetals and Mining

Assessing Algoma Steel Group (NasdaqGM:ASTL) Valuation After Hanwha Ocean Defense Agreement Spurs Fresh Interest

Why Algoma Steel Group (ASTL) Is Back On Investors’ Radar Algoma Steel Group (NasdaqGM:ASTL) is in focus after signing a binding memorandum of understanding with Hanwha Ocean related to Canada’s Patrol Submarine Project. The agreement outlines a potential US$250 million package of mill investment and steel purchases. See our latest analysis for Algoma Steel Group. The Hanwha Ocean agreement comes at a time when Algoma Steel Group’s share price has shown short-term momentum, with a 7-day share...
NYSE:GPI
NYSE:GPISpecialty Retail

Group 1 Automotive Buyback Completion Reshapes EPS And Capital Allocation Choices

Group 1 Automotive completed a major phase of its share repurchase program, retiring more than 47% of its shares since 2020. The company, listed as NYSE:GPI, has been using buybacks as a key tool to return capital to shareholders. This reduction in share count may influence future earnings per share calculations and management's capital allocation decisions. For investors watching NYSE:GPI, the completion of this large buyback phase comes with the stock recently closing at $396.41. Over the...
NasdaqGS:NXT
NasdaqGS:NXTElectrical

Nextpower (NXT) Margin Compression Challenges Bullish Earnings Narrative After Q3 2026 Results

Nextpower (NXT) just posted its Q3 2026 scorecard, with revenue of US$909.4 million and basic EPS of US$0.88, alongside trailing twelve month revenue of about US$3.6 billion and EPS of US$4.03 that frame the latest quarter in a broader context. Over recent quarters, the company has seen revenue move from US$679.4 million in Q3 2025 to US$909.4 million in Q3 2026, while quarterly EPS has ranged from US$0.80 to US$1.08 across that period. This sets up a story where solid recent earnings are now...
NYSE:EFC
NYSE:EFCMortgage REITs

3 Stocks That May Be Trading Below Estimated Value In January 2026

As the U.S. stock market experiences fluctuations driven by mixed corporate earnings and geopolitical uncertainties, investors are increasingly attentive to undervalued opportunities amidst the volatility. In such a climate, identifying stocks that may be trading below their estimated value can offer potential for growth, provided they exhibit strong fundamentals and resilience in challenging conditions.
NasdaqGS:GLOO
NasdaqGS:GLOOSoftware

Gloo Holdings And 2 More High Growth Companies With Strong Insider Ownership

As the U.S. stock market faces turbulence with major indices like the Dow Jones and S&P 500 experiencing declines, investors are keenly observing companies that exhibit resilience and potential for growth. In such a volatile environment, stocks of growth companies with high insider ownership often stand out as they suggest strong internal confidence in the business's future prospects.
NYSE:RNGR
NYSE:RNGREnergy Services

Discover 3 Undiscovered Gems in the US Market

As the U.S. market navigates a landscape marked by fluctuating tech stocks and record highs in precious metals, investors are increasingly looking beyond the well-trodden paths of major indices to uncover potential opportunities in lesser-known small-cap stocks. In this environment, identifying undiscovered gems requires a keen eye for companies with robust fundamentals that can withstand broader market volatility and capitalize on niche growth opportunities.
NYSEAM:CET
NYSEAM:CETCapital Markets

3 Reliable Dividend Stocks Offering Up To 7.7% Yield

As the U.S. stock market navigates through a challenging period marked by declining tech shares and fluctuating precious metal prices, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, providing both potential for growth and regular returns that may help cushion against market downturns.
NasdaqGS:PCH
NasdaqGS:PCHSpecialized REITs

Assessing PotlatchDeltic (PCH) Valuation After Gradual Share Price Momentum And Rich Earnings Multiple

What Recent Performance Says About PotlatchDeltic PotlatchDeltic (PCH) has drawn investor attention after a mix of short term weakness and modest recent gains, with the share price down over the past week but up over the past month and past 3 months. See our latest analysis for PotlatchDeltic. That mix of near term weakness and recent gains fits a broader pattern, with the 30 day share price return of 3.78% and year to date share price return of 4.31% sitting against a 1 year total...